Allurion: first HealthTech IPO of 2023 via SPAC with Compute Health
Lloyd Price
AUGUST 5, 2023
Additionally, the company has been criticized for its high price tag. Allurion's venture capital investors believe that the company has the potential to become a major player in the weight loss market. In addition to venture capital funding, Allurion has also received funding from the National Institutes of Health (NIH).
52 
Let's personalize your content